In this interview, Aaron Keay, CEO of ABcann Global Corporation, speaks with Natasha Frakes about why the company waited two years from getting their license before going public, the factors that differentiate the company from competitors, as well as their strategy in the Canadian marketplace. Aaron discusses how the company manages the health of its plants in order to ensure that deviation and variance in the product is minimal. He goes on to explain how the company’s path to success in Canada is based on a scaling method, which allows the company to grow one premium product with an increased production capacity.
Read More
